ClearRead CT vs PMcardio
AI Verdict
Choose ClearRead CT if…
Choose ClearRead CT if your radiology department needs to enhance the detection and characterization of pulmonary nodules and analyze coronary artery calcification from CT scans. It's particularly well-suited for improving diagnostic accuracy, reducing reading times, and streamlining workflows in lung cancer screening programs and general cardiothoracic imaging by suppressing vessels and machine noise for a clearer view.
View ClearRead CT →Choose PMcardio if…
Choose PMcardio if your healthcare setting requires rapid, AI-powered interpretation of ECGs for the assessment of over 50 cardiac conditions, especially at the point of care or in emergency situations. It is ideal for clinicians who need instant, expert-level ECG analysis, including STEMI/OMI detection and reduced LVEF detection, with guideline-adherent treatment recommendations and seamless integration into mobile, web, or EHR/CVIS platforms.
View PMcardio →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ClearRead CT | PMcardio |
|---|---|---|
| Pricing | Contact for pricing | Freemium |
| Deployment | On-premise (stand-alone server, virtual machine) and Cloud | Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems |
| FDA Status | 1 AI-estimated | Pending AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
PMcardioPMcardio offers a mobile app and web platform, allowing for instant AI-powered ECG interpretations by simply snapping a photo of a 12-lead ECG. This broad accessibility and ease of use at the point of care, including a free plan, make it highly usable for a wide range of healthcare professionals. ClearRead CT, while integrating seamlessly into PACS, is primarily designed for radiologists reviewing CT scans, which is a more specialized workflow.
Clinical Value
PMcardioPMcardio has been clinically validated in over 25 studies, demonstrating superior accuracy in detecting over 50 cardiac conditions, including early STEMI detection with twice the sensitivity of standard care and a significant reduction in false STEMI alarms. ClearRead CT also shows strong clinical value with a 29% reduction in missed actionable nodules and 36% faster reading times for radiologists. However, PMcardio's broader impact across various cardiac conditions and its potential for earlier intervention at the point of care give it a slight edge in overall clinical value.
Pricing & Value
PMcardioPMcardio offers a transparent freemium model with a free plan for individuals and clear pricing for teams and organizations, making it accessible for individual clinicians to try and adopt. ClearRead CT requires contacting the vendor for pricing details, which suggests a less transparent and potentially higher-cost enterprise-focused model. PMcardio's clear pricing structure and free tier offer greater value.
Enterprise Readiness
PMcardioBoth tools demonstrate strong enterprise readiness. ClearRead CT is designed for enterprise-wide deployment, seamlessly integrating with PACS and processing scans from various CT manufacturers. PMcardio also offers enterprise integrations with EHR/CVIS and EMS systems, supports regional data residency, role-based access control, SSO, and full audit trails, and has been adopted by over 50 health systems. PMcardio's comprehensive suite of enterprise features, including unified AI models and end-to-end pathway coverage, gives it an advantage in managing the full cardiac care journey across an organization.
Innovation
PMcardioPMcardio showcases significant innovation with its AI explainability feature (ECGxplainu2122) using heatmaps, and its ability to detect over 50 cardiac conditions from ECGs, including reduced LVEF and culprit artery prediction. ClearRead CT's patented vessel suppression technology and its FDA clearance for concurrent reading are also innovative, improving nodule conspicuity and reading efficiency. However, PMcardio's visual AI explainability and broader diagnostic scope from a single modality represent a more forward-thinking approach to AI in cardiology.
Support & Docs
PMcardioPMcardio provides a Help Center with user-friendly tutorials and manuals, FAQs, and regulatory documentation, indicating robust support for its users. ClearRead CT's documentation and support details are less explicitly outlined in the provided information, though its deployment in numerous healthcare institutions suggests adequate underlying support. PMcardio's readily available and detailed support resources give it an edge.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ClearRead CT | PMcardio |
|---|---|---|
| Tool Name | ClearRead CT | PMcardio |
| Company | RIVERAIN TECHNOLOGIES | Powerful Medical |
| Description | ClearRead CT is an FDA-cleared AI suite by Riverain Technologies for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. It improves diagnostic accuracy, reduces reading times, and streamlines radiology workflows through advanced AI and vessel suppression technology. | PMcardio is a CE-certified AI platform that interprets ECGs to assess over 50 cardiac conditions rapidly and accurately. Clinically validated in more than 25 studies and trusted by over 100,000 clinicians, it delivers rapid, expert-level interpretations, empowering various healthcare professionals to act with confidence at the point of care. |
| Regulatory Clearance | FDA-cleared | CE-certified (Class IIb EU MDR). FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model. |
| Key Features | Pulmonary Nodule Detection (solid, part-solid, ground glass), Patented Vessel Suppression (Clear Visual Intelligence), Nodule Characterization and Measurement (volume, diameter, location, type, depth), Automated Nodule Tracking and Comparison to Prior Exams, Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs), Reduced Reading Time (up to 36%), Improved Detection Accuracy (29% reduction in missed actionable nodules), Seamless PACS Integration / Vendor-neutral processing | Instant AI-powered ECG interpretations, Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders), Queen of Heartsu2122 - STEMI and OMI Detection, LVsenseu2122 - Reduced LVEF Detection, ECGxplainu2122 - Visual AI Explainability with heatmaps, Core AI - Detects 36 core diagnoses (arrhythmias, conduction blocks, heart blocks, chamber hypertrophies), Automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals, Culprit Artery AI confidence scores with 3D heart visualization |
| Categories | Cardiology AI, Oncology AI, Radiology & Imaging AI | Cardiology AI, Clinical Decision Support & Reference |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring ClearRead CT and PMcardio.